The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
Blood. 2020 May 21;135(21):1912-1915. doi: 10.1182/blood.2020006288.
Blood. 2020.
PMID: 32302379
Free PMC article.
No abstract available.